Jan C. Schuller

828 total citations
19 papers, 624 citations indexed

About

Jan C. Schuller is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jan C. Schuller has authored 19 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jan C. Schuller's work include Esophageal Cancer Research and Treatment (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Esophageal and GI Pathology (5 papers). Jan C. Schuller is often cited by papers focused on Esophageal Cancer Research and Treatment (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Esophageal and GI Pathology (5 papers). Jan C. Schuller collaborates with scholars based in Switzerland, Netherlands and Italy. Jan C. Schuller's co-authors include C. Ares, Beate Timmermann, Antony Lomax, Eugen B. Hug, Hans Rutz, Eros Pedroni, Gudrun Goitein, Alessandra Bolsi, Thomas Ruhstaller and Roger von Moos and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

Jan C. Schuller

19 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan C. Schuller Switzerland	11	387	312	127	90	71	19	624
G S Weinstein United States	17	263 0.7×	402 1.3×	86 0.7×	56 0.6×	232 3.3×	38	983
Ali Sarıkaya Türkiye	16	150 0.4×	213 0.7×	35 0.3×	22 0.2×	96 1.4×	70	676
Mansi A. Saksena United States	16	267 0.7×	218 0.7×	65 0.5×	7 0.1×	114 1.6×	33	797
Min‐Sik Kim South Korea	21	269 0.7×	678 2.2×	11 0.1×	46 0.5×	317 4.5×	68	1.2k
Roberto Scipione Italy	9	146 0.4×	87 0.3×	69 0.5×	12 0.1×	49 0.7×	17	381
Jorge Casas-Ganem United States	8	195 0.5×	172 0.6×	128 1.0×	55 0.6×	183 2.6×	9	526
Sei Young Lee South Korea	14	192 0.5×	222 0.7×	75 0.6×	72 0.8×	121 1.7×	32	606
Gianluca Scalia Italy	14	140 0.4×	328 1.1×	64 0.5×	15 0.2×	48 0.7×	156	766
Ajit Shinto India	14	188 0.5×	139 0.4×	44 0.3×	4 0.0×	144 2.0×	84	601
Vibhu Kapoor United States	14	269 0.7×	332 1.1×	17 0.1×	8 0.1×	81 1.1×	20	669

Countries citing papers authored by Jan C. Schuller

Since Specialization

Citations

This map shows the geographic impact of Jan C. Schuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan C. Schuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan C. Schuller more than expected).

Fields of papers citing papers by Jan C. Schuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan C. Schuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan C. Schuller. The network helps show where Jan C. Schuller may publish in the future.

Co-authorship network of co-authors of Jan C. Schuller

This figure shows the co-authorship network connecting the top 25 collaborators of Jan C. Schuller. A scholar is included among the top collaborators of Jan C. Schuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan C. Schuller. Jan C. Schuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Mamot, Christoph, Reto Ritschard, Andreas Wicki, et al.. (2012). Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells. Journal of drug targeting. 20(5). 422–432. 42 indexed citations

Schuller, Jan C.. (2011). The malicious host: a minimax solution of the Monty Hall problem. Journal of Applied Statistics. 39(1). 215–221. 3 indexed citations

Biffi, Roberto, Nicola Fazio, Fabrizio Luca, et al.. (2010). Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer.. PubMed. 16(7). 868–74. 68 indexed citations

Leupin, Nicolas, Jan C. Schuller, Max Solenthaler, et al.. (2010). Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02). Leukemia & lymphoma. 51(4). 613–619. 6 indexed citations

Jöst, Christian, Janek Binek, Jan C. Schuller, et al.. (2010). Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02). Gastrointestinal Endoscopy. 71(7). 1114–1121. 28 indexed citations

Ruhstaller, Thomas, Arnoud J. Templeton, Karin Ribi, et al.. (2010). Intense Therapy in Patients with Locally Advanced Esophageal Cancer beyond Hope for Surgical Cure: A Prospective, Multicenter Phase II Trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02). Onkologie. 33(5). 222–228. 7 indexed citations

Schuller, Jan C., Michael Mayer, Doris Lanz, et al.. (2009). A novel diagram and complement to the CONSORT chart for presenting multimodal clinical trials. Contemporary Clinical Trials. 30(3). 201–204. 2 indexed citations

Ribi, Karin, Dieter Koeberle, Jan C. Schuller, et al.. (2009). Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?. Supportive Care in Cancer. 17(8). 1109–1116. 18 indexed citations

Ruhstaller, Thomas, Jan C. Schuller, A. Roth, et al.. (2009). Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of Oncology. 20(9). 1522–1528. 60 indexed citations

10.

Ares, C., Eugen B. Hug, Antony Lomax, et al.. (2009). Effectiveness and Safety of Spot Scanning Proton Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base: First Long-Term Report. International Journal of Radiation Oncology*Biology*Physics. 75(4). 1111–1118. 195 indexed citations

11.

Klaeser, Bernd, Egbert Nitzsche, Jan C. Schuller, et al.. (2009). Limited Predictive Value of FDG-PET for Response Assessment in the Preoperative Treatment of Esophageal Cancer: Results of a Prospective Multi-Center Trial (SAKK 75/02). Onkologie. 32(12). 724–730. 42 indexed citations

12.

Ruhstaller, Thomas, Miklos Pless, Jan C. Schuller, et al.. (2009). Cetuximab in combination with chemoradiotherapy prior to surgery in patients with resectable, locally advanced esophageal carcinoma: A prospective, multicenter phase lb-ll trial of the Swiss Group for Clinical Cancer Research (SAKK 75/06). Journal of Clinical Oncology. 27(15_suppl). 4570–4570. 5 indexed citations

13.

Schuller, Jan C., Walter Mingrone, Viviane Hess, et al.. (2008). Preoperative induction chemotherapy with docetaxel-cisplatin followed by concurrent docetaxel-cisplatin and radiation therapy (RT) in patients with locally advanced esophageal cancer: Final results of the multicenter phase ll trial SAKK 75/02. Journal of Clinical Oncology. 26(15_suppl). 4550–4550. 4 indexed citations

14.

Ribi, Karin, Jürg Bernhard, Jan C. Schuller, et al.. (2008). Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: Feasibility and responsiveness to clinical changes. Lung Cancer. 61(3). 398–404. 23 indexed citations

15.

Leupin, Nicolas, Jan C. Schuller, Max Solenthaler, et al.. (2007). The Combination of 2-CDA and Rituximab in Patients with Chronic Lymphocytic Leukemia (CLL): A Prospective Multicenter Phase II Trial (SAKK 34/02).. Blood. 110(11). 2057–2057. 1 indexed citations

16.

Ribi, Karin, Egbert Nitzsche, Jan C. Schuller, et al.. (2007). PET scanning and patient reported dysphagia before and after chemotherapy (CT) for prediction of pathological response after CT and chemoradiotherapy (CRT) in patients with locally advanced esophageal cancer (EC): A multicenter phase ll trial of the Swiss. Journal of Clinical Oncology. 25(18_suppl). 4587–4587. 1 indexed citations

17.

Gasser, Théo, et al.. (2005). Correction of muscle artefacts in the EEG power spectrum. Clinical Neurophysiology. 116(9). 2044–2050. 31 indexed citations

18.

Seynaeve, C., Jan C. Schuller, K. Buser, et al.. (1992). Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. British Journal of Cancer. 66(1). 192–197. 74 indexed citations

19.

Böhle, Andreas, Jan C. Schuller, A. Knipper, & A Hofstetter. (1990). Bacillus Calmette-Guérin Treatment and Vesicorenal Reflux. European Urology. 17(2). 125–128. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact